VCJ Staff

Risk I/O Wraps Up $5.25M Series A

Risk I/O, maker of a vulnerability intelligence platform, has raised $5.25 million in a Series A round led by U.S. Venture Partners. Tugboat Ventures and Greg Sands' Costanoa Venture Capital also contributed. As a result, USVP partner Jacques Benkoski joins the company’s board. The company is based in Chicago.

Epic Sciences Closes on $13M

Epic Sciences Inc., a biotech company focused on cancer diagnostics, has raised $13 million in Series B financing. The financing includes new investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments.

Retrofit Inks $8M

Chicago-based Retrofit, maker of a data-driven weight loss program, has raised $8 million in Series A financing. Draper Fisher Jurvetson led the round, investing $6 million. Correlation Ventures, Hyde Park Angels, New World Ventures and I2A Fund also participated.

Pearl Therapeutics Closes $65M Series D

Pearl Therapeutics Inc., a biopharma company, has raised $65 million in Series D financing from current investors including 5AM Ventures, Clarus Ventures and New Leaf Venture Partners. Vatera Healthcare Partners led the round. With this infusion, Pearl will have raised a total of $167.5 million since 2007.

Platfora Closes $20M Series B

San Mateo, Calif.-based Platfora, an in-memory business intelligence platform for Hadoop and Big Data, has raised $20 million in Series B financing. Battery Ventures led the round, with participation from existing investors Andreessen Horowitz and Sutter Hill Ventures. In-Q-Tel is also an investor in Platfora. As a result of the round, Battery’s Roger Lee joins the Platfora board. The company will use the new funds to expand sales and marketing and continue building out its product engineering and design teams.

Motorola Backs TRX Systems

Motorola Solutions Venture Capital, the investment arm of Motorola Solutions Inc., has invested in TRX Systems Inc. The investment is part of a $2 million Series A round. New Dominion Angels, the Maryland Department of Economic Development and other undisclosed investors also participated.

DoubleDutch Inks $4M

DoubleDutch, a maker of mobile CRM applications, has raised $4 million in Series B financing. FLOODGATE Fund led the round, with participation from Bullpen Capital and Lightbank. Mike Maples Jr., managing partner at FLOODGATE, will join DoubleDutch’s board.

Intronis Closes $12M Round

Intronis Inc., a maker of cloud backup technology, has raised $12 million in new funding led by Greenspring Associates, a new investor in the company. OpenView Venture Partners and the company’s executive management team also participated.

Visterra Adds $13M to Wrap Up Series A

Cambridge, Mass.-based Visterra has raised $13 million to complete a Series A financing round with a total of $26 million, the company said. Visterra develops medicines to prevent and treat infectious and other major diseases. The Bill & Melinda Gates Foundation and Omega Funds participated with the existing investors Polaris Venture Partners, Flagship Ventures and Lux Capital.

Sensimed Holds First Close for Series C

Sensimed AG said that it has held a first close of its Series C round, netting $17.9 million. Wellington Partners, Agate Medical Investments and Vinci Capital/Renaissance PME co-led the round. Other investors include Sandoz Family Foundation and ELM Development. Sensimed AG, a Swiss company, develops a “non-invasive soft contact lens-based solution” to help treat glaucoma.